EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Diagnostic Medical Systems's Enterprise Value is €44.33 Mil.
Diagnostic Medical Systems's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was €0.03 Mil. Therefore, Diagnostic Medical Systems's EV-to-FCF for today is 1,477.63.
The historical rank and industry rank for Diagnostic Medical Systems's EV-to-FCF or its related term are showing as below:
FRA:DMS1'
s EV-to-FCF Range Over the Past 10 Years
Min: -19.49 Med: -6.18 Max: 1593.27
Current: 1477.5
During the past 13 years, the highest EV-to-FCF of Diagnostic Medical Systems was 1593.27. The lowest was -19.49. And the median was -6.18.
FRA:DMS1's EV-to-FCF is ranked worse than 98.56% of 418
companies
in the Medical Devices & Instruments industry
Industry Median: 23.12
vs FRA:DMS1: 1477.50
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Diagnostic Medical Systems (FRA:DMS1) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Diagnostic Medical Systems's PE Ratio (TTM) for today is calculated as:
Diagnostic Medical Systems's share price for today is €1.115.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Diagnostic Medical Systems's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was €-0.140.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Diagnostic Medical Systems EV-to-FCF Related Terms
Diagnostic Medical Systems EV-to-FCF Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Diagnostic Medical Systems's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Diagnostic Medical Systems EV-to-FCF vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Diagnostic Medical Systems's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Diagnostic Medical Systems's EV-to-FCF falls into.
Diagnostic Medical Systems's current Enterprise Value is €44.33 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Diagnostic Medical Systems's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was €0.03 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Diagnostic Medical Systems (FRA:DMS1) has a EV-to-FCF of 1,477.63 as of Jul. 04, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Diagnostic Medical Systems and its competitors. According to the industry distribution chart, Diagnostic Medical Systems ranks #412 out of 418 companies in the Medical Devices & Instruments industry, placing it in the top 98.6%.
Is Diagnostic Medical Systems' EV-to-FCF too high?
Diagnostic Medical Systems' current EV-to-FCF is 1,477.63. The Medical Devices & Instruments industry median EV-to-FCF is 23.12. Diagnostic Medical Systems' value of 1,477.63 is 6291.1% above this industry median. Based on the distribution chart, Diagnostic Medical Systems ranks #412 out of 418 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Diagnostic Medical Systems has a GF Score™ of 65/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Diagnostic Medical Systems' EV-to-FCF compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Diagnostic Medical Systems ranks #412 out of 418 companies for EV-to-FCF. This places Diagnostic Medical Systems in the lower half of its industry. The industry median EV-to-FCF is 23.12. Diagnostic Medical Systems' value of 1,477.63 is 6291.1% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Medical Devices & Instruments company?
The median EV-to-FCF among Medical Devices & Instruments companies is 23.12, based on 418 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Diagnostic Medical Systems's current EV-to-FCF of 1,477.63 is 6291.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Diagnostic Medical Systems and its competitors. For the Medical Devices & Instruments industry, the median EV-to-FCF is 23.12 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Diagnostic Medical Systems's current EV-to-FCF is 1,477.63. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Diagnostic Medical Systems stock overvalued right now?
Based on GuruFocus' analysis, Diagnostic Medical Systems (FRA:DMS1) is currently considered Fairly Valued. The stock's GF Value™ is €1.03, compared to a current price of €1.12 — trading 8.3% above its estimated fair value. The current EV-to-FCF is 1,477.63 and 6291.1% above the Medical Devices & Instruments industry median of 23.12. Diagnostic Medical Systems' overall GF Score™ is 65/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Diagnostic Medical Systems (FRA:DMS1), the current EV-to-FCF is 1,477.63 as of Jul. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Diagnostic Medical Systems (FRA:DMS1) Overvalued in 2026?
Based on GuruFocus' analysis, Diagnostic Medical Systems stock appears to be overvalued.
The current stock price of €1.12 is trading 8.3% above its estimated GF Value™ of €1.03.
GuruFocus considers Diagnostic Medical Systems to be Fairly Valued.
Key valuation signals for FRA:DMS1:
EV-to-FCF: 1,477.63
GF Value™: €1.03 vs. price of €1.12 (8.3% above fair value)
Industry Position: 6291.1% above the Medical Devices & Instruments median (#412 of 418)
No single metric tells the full story. See the FRA:DMS1 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Diagnostic Medical Systems is France's company engaged in the development, design, and production of imaging systems for digital and conventional radiology and osteodensitometry. The group's activity is organized around two sectors: Radiology equipment and osteodensitometers sales: mobile radiology units, floating table tops, operating room mobile amplifiers, ultrasound osteodensitometers (designed to chart the bone micro-architecture) and X ray osteodensitometers (designed to measure bone density), etc. The group also proposes devices distribution and maintenance activities; and the Development of biotechnology solutions: in the fields of arthrosis treatment and regenerative medicine.
65GF Score
Get the complete analysis for FRA:DMS1
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:DMS1 has been successfully added to your 
